Literature DB >> 3408644

Expression and enhanced secretion of proteochondroitin sulphate in a metastatic variant of a mouse lymphoma cell line.

R Schwartz-Albiez1, I Steffen, A Lison, N Güttler, V Schirrmacher, R Keller.   

Abstract

Even though many studies suggest that proteoglycans with their structurally determinative polysaccharide chains, the glycosaminoglycans (GAGs), are important mediators of cellular interactions, little is known about expression and possible functions of these macromolecules expressed by tumour cells during the transition from low to highly metastatic behaviour. Therefore, we investigated the cellular expression and secretion of GAGs in a syngeneic tumour system of DBA/2 mice consisting of a methylcholanthrene-induced low metastatic T lymphoma (Eb), its highly metastatic spontaneous variant (ESb), and a low metastatic derivative of ESb (ESb-MP), selected by its adherent growth properties. The [35S]-sulphate-labelled GAGs were isolated from in vitro cultivated cells and further characterized by separation on Sepharose CL 6B, on Mono-Q ion exchange chromatography, and alkali- and enzymatic digestion. In contrast to Eb-cells which produce chondroitin/dermatan sulphate (CS/DS) and heparan sulphate (HS) (cellular extract: CS/DS 67%, HS 33%; culture medium: CS/DS 61%, HS 39%) ESb- and ESb-MP-cells only express and secrete CS/DS. For ESb cells the CS portions consisted of 42% chondroitin-4-sulphate (CS-4) and 58% chondroitin-6-sulphate (CS-6), for ESb-MP cells of 23% CS-4 and 77% CS-6, for Eb cells of 16% CS-4 and 84% CS-6. The cell surface GAGs of the adherent variant ESb-MP contained a significantly higher portion of DS (65%) compared to ESb cells (25%). GAGs of all tumour cell lines studied had a mol. wt ranging from 35-40 kD compared to GAG molecular weight standards. Ion exchange chromatography indicated that differences in charge density between GAGs of these cell lines were minimal. These findings suggest that the different biological behaviour of the cell lines cannot be attributed to altered size and charge density of their GAG chains. However, highly metastatic ESb-cells secreted significantly more GAG than low metastatic Eb- and ESb-MP-cells. The possible consequences of the enhanced secretion of CS/DS by ESb-cells are discussed in terms of the postulated role of CS/DS in cellular adhesion, growth regulation and interactions with the immune system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3408644      PMCID: PMC2246466          DOI: 10.1038/bjc.1988.130

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  38 in total

1.  A transformation-dependent difference in the heparan sulfate associated with the cell surface.

Authors:  C B Underhill; J M Keller
Journal:  Biochem Biophys Res Commun       Date:  1975-03-17       Impact factor: 3.575

2.  Isolation of glycosaminoglycans from lymphocytes in chronic lymphoic leukemia.

Authors:  J Capeau; J Picard; A Paul-Gardais
Journal:  Biomedicine       Date:  1978-05

3.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.

Authors:  V Schirrmacher; G Shantz; K Clauer; D Komitowski; H P Zimmermann; M L Lohmann-Matthes
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

4.  Co-polymeric glycosaminoglycans in transformed cells. Transformation-dependent changes in the self-associating properties of cell-surface heparan sulfate.

Authors:  L A Fransson; I Sjöberg; V P Chiarugi
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

5.  Studies on the polydispersity and heterogeneity of proteokeratan sulfate from calf and porcine cornea.

Authors:  H W Stuhlsatz; F Hirtzel; R Keller; S Cosma; H Greiling
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1981-07

6.  Heparan sulfates from Swiss mouse 3T3 and SV3T3 cells: O-sulfate difference.

Authors:  K L Keller; J M Keller; J N Moy
Journal:  Biochemistry       Date:  1980-05-27       Impact factor: 3.162

7.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.

Authors:  V Schirrmacher; K Bosslet; G Shantz; K Clauer; D Hübsch
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

8.  The C1q inhibitor in serum is a chondroitin 4-sulfate proteoglycan.

Authors:  L Silvestri; J R Baker; L Rodén; R M Stroud
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

9.  Changes in tumor cell adhesiveness affecting speed of dissemination and mode of metastatic growth.

Authors:  R Benke; E Lang; D Komitowski; S Muto; V Schirrmacher
Journal:  Invasion Metastasis       Date:  1988

10.  Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with reduced degree of sulfation.

Authors:  D J Winterbourne; P T Mora
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

View more
  2 in total

1.  Two human melanoma xenografts with different metastatic capacity and glycosaminoglycan pattern.

Authors:  J Timár; I Kovalszky; S Paku; K Lapis; L Kopper
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  Role of Proteoglycans in Tumor Progression.

Authors:  József Timár; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.